Authors:
Baettig, U
Brown, L
Brundish, D
Dell, C
Furzer, A
Garman, S
Janus, D
Kane, PD
Smith, G
Walker, CV
Cockcroft, XL
Ambler, J
Mitchelson, A
Talbot, MD
Tweed, M
Wills, N
Citation: U. Baettig et al., The design and synthesis of thrombin inhibitors: Analogues of MD805 containing non-polar surrogates for arginine at the P1 position, BIOORG MED, 10(14), 2000, pp. 1563-1566
Authors:
Hayler, J
Kane, PD
LeGrand, D
Lugrin, F
Menear, K
Price, R
Allen, M
Cockcroft, XL
Ambler, J
Butler, K
Dunnet, K
Mitchelson, A
Talbot, M
Tweed, M
Wills, N
Citation: J. Hayler et al., The design and synthesis of thrombin inhibitors: The introduction of in vivo efficacy and oral bioavailability into benzthiazolylalanine inhibitors, BIOORG MED, 10(14), 2000, pp. 1567-1570
Authors:
Brundish, D
Bull, A
Donovan, V
Fullerton, JD
German, SM
Hayler, JF
Janus, D
Kane, PD
McDonnell, M
Smith, GP
Wakeford, R
Walker, CV
Howarth, G
Hoyle, W
Allen, MC
Ambler, J
Butler, K
Talbot, MD
Citation: D. Brundish et al., Design and synthesis of thrombin inhibitors: Analogues of MD-805 with reduced stereogenicity and improved potency, J MED CHEM, 42(22), 1999, pp. 4584-4603